Hila Barak

Hila Barak, PhD, RAC, currently serves as the Head of Oncology Clinical Science and Chief of Staff at Gilead Sciences, where responsibilities include leading the Oncology Clinical Research Group, driving strategic initiatives, and managing the Gilead HOPE Network. Prior experience includes roles at Genentech as Global Clinical Lead for the Morpheus Platform and Associate Group Clinical Science Director, as well as positions at Baxalta and Baxter International Inc., where Hila managed oncology clinical studies and medical affairs. Academic background features a PhD in Biology from the Technion - Israel Institute of Technology and a B.Sc. in Biochemistry and Food Technology from The Hebrew University of Jerusalem, supplemented by teaching and research experiences at prestigious institutions, including Washington University School of Medicine.